672
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetic evaluation of C-3 modified 1,8-naphthyridine-3-carboxamide derivatives with potent anticancer activity: lead finding

, , , &
Pages 710-721 | Received 20 Mar 2013, Accepted 11 Sep 2013, Published online: 24 Oct 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jiayi Wang, Dongning Sheng, Duo Fu & Jiaxi Xu. (2023) Convenient synthesis of N-sulfonyl α-hydroxyamides via DMSO oxidation of N-alk-1-ynylsulfonamides. Journal of Sulfur Chemistry 44:5, pages 505-522.
Read now

Articles from other publishers (11)

Kapil Chahal, Damera Vani, Kothuri Pranay, Inapanuri Madhu, Balasubramanian Sridhar & Kallu Rajender Reddy. (2023) Silver Catalyzed Cascade Strategy for the Synthesis of Diversely Substituted Polycyclic Fused 1,7‐Naphthyridine Scaffolds. ChemistrySelect 8:45.
Crossref
Singamsetty Rangaswamy, Reddymasu Sreenivasulu, Vankayala Ramesh Babu, Tasqeeruddin Syed, Ravi Kumar Kapavarapu, Hulikunte Veeranna Jayaprakash & Venkata Durga Nagendra Kumar Abbaraju. (2023) Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Oxazole‐Incorporated Naphthyridine Derivatives. Chemistry & Biodiversity.
Crossref
Fekadu Muleta, Tegene Desalegn, Taye B. Demissie, Rajalakshmanan Eswaramoorthy, H.C. Ananda Murthy, Kah-Yoong Chan, Bianca L. Davids & Kennedy J. Ngwira. (2023) Synthesis, molecular docking, and biological studies of novel heteroleptic Cu(II) and Zn(II) complexes of natural product-based semicarbazone derivatives. Journal of Molecular Structure 1274, pages 134405.
Crossref
Fekadu Muleta, Tegene Desalegn, Rajalakshmanan Eswaramoorthy & Ankita Garg. (2022) Synthesis, characterization, in-silico, and in-vitro biological studies of Cu(II), Zn(II) complexes of semicarbazone, thiosemicarbazone derivatives of dehydrozingerone. Journal of Molecular Structure 1268, pages 133632.
Crossref
Fekadu Muleta & Tegene Desalegn. (2022) Synthesis, In Silico, and Biological Applications of Novel Heteroleptic Copper (II) Complex of Natural Product-Based Semicarbazone Ligands. Journal of Chemistry 2022, pages 1-17.
Crossref
Yoseph Samuel, Ankita Garg & Endale Mulugeta. (2021) Synthesis, DFT Analysis, and Evaluation of Antibacterial and Antioxidant Activities of Sulfathiazole Derivatives Combined with In Silico Molecular Docking and ADMET Predictions. Biochemistry Research International 2021, pages 1-14.
Crossref
Ankita Garg, Aschalew Tadesse & Rajalakshmanan Eswaramoorthy. (2021) A Four-Component Domino Reaction: An Eco-Compatible and Highly Efficient Construction of 1,8-Naphthyridine Derivatives, Their In Silico Molecular Docking, Drug Likeness, ADME, and Toxicity Studies. Journal of Chemistry 2021, pages 1-16.
Crossref
Madhwi Ojha, Divya Yadav, Avinash Kumar, Suman Dasgupta & Rakesh Yadav. (2021) 1,8-Naphthyridine Derivatives: A Privileged Scaffold for Versatile Biological Activities. Mini-Reviews in Medicinal Chemistry 21:5, pages 586-601.
Crossref
Guodong MaJiping ZhuFeng LiuYan Yang. (2019) Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p. DNA and Cell Biology 38:2, pages 176-183.
Crossref
Qingle Zeng, Li Zhang & Yue Zhou. (2018) Advances in Selective Carbon-Heteroatom Coupling Reactions. The Chemical Record 18:9, pages 1278-1291.
Crossref
Alka Madaan, Ritu Verma, Vivek Kumar, Anu T. Singh, Swatantra K. Jain & Manu Jaggi. (2015) 1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities. Archiv der Pharmazie 348:12, pages 837-860.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.